Matrix Capital Management Company, LP
At a glance: Matrix Capital Management Company, LP is 10% Owner at Aura Biosciences (AURA). Their latest SEC Form 4, filed May 11, 2026, reported a sale of $39.0M. On file: 0 purchase lines ($0) and 1 sale line ($39.0M).
10% Owner at Aura Biosciences, Inc. (AURA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Matrix Capital Management Company, LP's InsiderPrint
4 trades from SEC Form 4 filings, 2022 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $39.0M a trade.
- Bump outward: a purchase (3)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Jay L. SchottensteinCEO, Chair · AEO · 98% matchTheir buys since 2020: 1 of 4 beat the S&P 500
- Roivant Sciences Ltd.Director · IMVT · 98% match
- Elon MuskCEO, CTO · SPCX · 97% match
- John G. DanhaklDirector · LTH · 96% match
- Oxford Science Enterprises PLCFormer 10% Owner · PEPG · 96% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2022
From the SEC's insider data sets: each open-market buy by Matrix Capital Management Company, LP, matched to how the stock did over the next 90 days against the S&P 500.
Reported trades
Follow Matrix Capital Management Company, LP
Get one email when Matrix Capital Management Company, LP files a new purchase or sale. Free.
At most one email a day about Matrix Capital Management Company, LP, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.